# CordenPharma Brussels SA – FDA Inspection, Feb 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/cordenpharma-brussels-sa/440f5678-e355-4991-98c0-7db346dc57b2
Source feed: FDA_Inspections

> FDA inspection 1005031 of CordenPharma Brussels SA, February 03, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005031
- Company Name: CordenPharma Brussels SA
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1167305 - 2020-01-31
- FDA Inspection 917907 - 2015-02-27
- FDA Inspection 819585 - 2013-01-30
- FDA Inspection 584458 - 2009-04-02

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/william-j-leonard/b2e10570-6c89-4f62-a0aa-baeea6373512)

Company: https://www.keypedia.com/companies/cordenpharma-brussels-sa/2f748258-ca7e-4e98-ba82-824fe80fdd75

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c